SCHEMBL27171252

SCHEMBL27171252

NNC(=O)N(Nc1ccccn1)C(=O)c1cc(-c2ccc(Cl)cc2)nn1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 2/20 0.46
▸ LMNA P02545 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HTT P42858 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ GRM5 P41594 3/20 0.43
▸ POLB P06746 1/20 0.41
▸ CCNA2 P20248 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ CXCR5 P32302 1/20 0.41
▸ APLNR P35414 1/20 0.41
▸ CCR6 P51684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30823700 0.84 PTPN1 (0.47) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL27171249 0.84 PTPN1 (0.47) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL30823695 0.79 ALDH1A1 (0.45) NTRK1LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL27171254 0.79 ALDH1A1 (0.45) NTRK1LMNAALDH1A1HTTSMN1; SMN2
SCHEMBL27171253 0.77 ALDH1A1 (0.46) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL26342427 0.76 LMNA (0.72) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL26341684 0.73 ALDH1A1 (0.62) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL26342422 0.72 MEN1 (0.62) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL27171246 0.71 EGFR (0.45) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL26342419 0.70 SMN1; SMN2 (0.62) LMNAALDH1A1HTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof NORTHWEST A&F UNIVERSITY (CN) 2026-05-05 — — US disclosed
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF NORTHWEST A&F UNIVERSITY (CN) 2024-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof GSTP1, GSTO1, GSTA1 NTRK1 2790/4885LMNA 4677/4885ALDH1A1 334/4885
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GSTP1, CYP4F11, GSTA1 NTRK1 4085/4885LMNA 4766/4885ALDH1A1 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback